Article

(2021) Mesoporous silica nanoparticles-based formulations of a chimeric proteinous vaccine candidate against necrotic enteritis disease. Materials Science & Engineering C-Materials for Biological Applications. p. 15. ISSN 0928-4931

(2021) Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. Journal of Nanobiotechnology. p. 27.

(2021) The design and production of engineered sta toxin as a vaccine candidate against enterotoxigenic Escherichia coli. Journal of Applied Biotechnology Reports. pp. 27-31. ISSN 23221186 (ISSN)

(2021) A meta-analysis of the efficiency of metal nanoparticles in vaccine delivery against infectious disease. Nanomedicine. 481-U20. ISSN 1743-5889

(2020) CRISPR-Based Diagnosis of Infectious and Noninfectious Diseases. Biological Procedures Online. p. 14.

(2019) Designing a multi-epitope vaccine for cross-protection against Shigella spp: An immunoinformatics and structural vaccinology study. Molecular Immunology. pp. 106-116. ISSN 0161-5890

(2019) Gentamicin-Loaded Chitosan Nanoparticles Improve Its Therapeutic Effects on Brucella-Infected J774A.1 Murine Cells. Galen Medical Journal. p. 9. ISSN 2588-2767

(2018) EspA-loaded mesoporous silica nanoparticles can efficiently protect animal model against enterohaemorrhagic E-coli O157: H7. Artificial Cells Nanomedicine and Biotechnology. S1067-S1075. ISSN 2169-1401

(2017) Analysis the Molecular Genetics Non-syndromic Hearing Loss (NHL). International Journal of Advanced Biotechnology and Research. pp. 2401-2410. ISSN 0976-2612

(2016) Design and in silico analysis of pentavalent chimeric antigen against three enteropathogenic bacteria: enterotoxigenic E. coli, enterohemorragic E. coli and Shigella. Bioscience Biotechnology Research Communications. pp. 229-243. ISSN 0974-6455

(2014) Nanoparticles in vaccine development. Journal of Applied Biotechnology Reports. pp. 125-134. ISSN 23221186 (ISSN)